Optimist Retirement Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.63M Sell
16,777
-21
-0.1% -$3.15K 1.01% 24
2026
Q1
$2.57M Sell
16,798
-2,181
-11% -$334K 1.13% 23
2025
Q4
$2.62M Sell
18,979
-340
-2% -$44.5K 1.2% 22
2025
Q3
$2.48M Buy
19,319
+47
+0.2% +$5.74K 1.12% 24
2025
Q2
$2.33M Buy
19,272
+69
+0.4% +$7.78K 1.12% 25
2025
Q1
$2.14M Buy
19,203
+137
+0.7% +$14.6K 1.07% 32
2024
Q4
$1.86M Sell
19,066
-247
-1% -$26.3K 0.88% 35
2024
Q3
$2.22M Buy
19,313
+166
+0.9% +$18.8K 1% 32
2024
Q2
$2.04M Buy
+19,147
New +$1.92M 1.07% 27

Other funds holding NVS

Optimist Retirement Group's NVS Position: Q2 2026 in Review

Optimist Retirement Group reduced its Novartis (NVS) stake by 0.13% in Q2 2026, selling an estimated $3.15K and leaving 16,777 shares worth $2.63M. The position accounts for 1.01% of the portfolio, ranked #24.

Optimist Retirement Group first reported a position in NVS in Q2 2024 and has held it in 9 quarters since. 1,621 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Optimist Retirement Group held 16,777 shares of Novartis worth $2.63M as of Q2 2026.
  • Optimist Retirement Group sold 21 Novartis shares in Q2 2026, an estimated $3.15K.
  • Novartis made up 1.01% of Optimist Retirement Group's portfolio in Q2 2026, its #24 holding.
  • Optimist Retirement Group first reported a position in Novartis in Q2 2024 and has held it in 9 quarters since.
  • 1,621 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Optimist Retirement Group's 13F filing for Q2 2026, filed 10 Aug 2026.